Publications by authors named "Cuzzocrea Marco"

Claim this Profile
T
The Prevalence and Malignancy Risk of Breast Incidental Uptake Detected by PET/CT with Different Radiopharmaceuticals: An Updated Systematic Review and Meta-Analysis.
Cesare Michele Iacovitti, Andreea Marin, Slavko Tasevski, Chiara Martinello, Marco Cuzzocrea

Pharmaceuticals (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNA.
Maria Cristina Pirosa, Alessio Bruscaggin, Lodovico Terzi di Bergamo, Matin Salehi, Federico Jauk, Marco Cuzzocrea

Blood· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Not All That Glitters Is Gold": Paraspinal Cavernous Hemangioma Mimicking Paraganglioma on Somatostatin Receptor PET/CT.
Cesare Michele Iacovitti, Ivan Cabrilo, Chiara Martinello, Marco Cuzzocrea, Gaetano Paone

Diagnostics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic value of dual-tracer PET/CT with [F]FDG and PSMA ligands in prostate cancer: an updated systematic review.
Cesare Michele Iacovitti, Marco Cuzzocrea, Alessio Rizzo, Matteo Bauckneht, Roberto C Delgado Bolton

Front Med (Lausanne)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Radioligand Therapy with Actinium-225 DOTATATE in Patients with Advanced, Metastatic or Inoperable Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis.
Alessio Rizzo, Alessio Imperiale, Salvatore Annunziata, Roberto C Delgado Bolton, Domenico Albano, Marco Cuzzocrea

Medicina (Kaunas)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis.
Barbara Muoio, Cesare Michele Iacovitti, Davide Giovanni Bosetti, Maddalena Sansovini, Marco Cuzzocrea

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of [F]FES PET/CT in Breast Cancer Management: An Umbrella Review.
Marco Cuzzocrea, Rosa Di Micco, Giorgia Elisabeth Colombo, Stefania Maria Rita Rizzo, Gaetano Paone

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Prevalence and Significance of Incidental Positron Emission Tomography Findings in the Brain Using Radiotracers Other than [F]FDG: A Systematic Review and Meta-Analysis.
Cesare Michele Iacovitti, Barbara Muoio, Domenico Albano, Alessio Rizzo, Marco Cuzzocrea

Diagnostics (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-Analysis on the Prevalence and Significance of Incidental Findings in the Thyroid Gland Using Other PET Radiopharmaceuticals Beyond [F]FDG.
Cesare Michele Iacovitti, Domenico Albano, Alessio Rizzo, Arnoldo Piccardo, Marco Cuzzocrea

Pharmaceuticals (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of 2-[F]FDG PET/CT in recurrent differentiated thyroid cancer and elevated antithyroglobulin antibodies: an updated systematic review and bivariate meta-analysis.
Domenico Albano, Arnoldo Piccardo, Alessio Rizzo, Marco Cuzzocrea, Gianluca Bottoni

Endocrine· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'Shining' infective endocarditis with a 'ring of fire' in the spleen.
Cesare Michele Iacovitti, Marco Cuzzocrea, Gaetano Paone, Giorgio Treglia

J Cardiovasc Med (Hagerstown)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastric Adenocarcinoma Incidentally Detected by PET/CT with PSMA Ligands.
Cesare Michele Iacovitti, Barbara Muoio, Marco Cuzzocrea, Gaetano Paone, Giorgio Treglia

Diagnostics (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Rosary Sign" at Somatostatin Receptor PET in a Case of Recurrent Meningioma.
Cesare Michele Iacovitti, Davide Giovanni Bosetti, Barbara Muoio, Marco Cuzzocrea, Gaetano Paone

Diagnostics (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Albumin-To-Alkaline Phosphatase Ratio as a New Early Predictive Marker of Axillary Response in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Pilot Study.
Rahel Felicia Mirjam Schmidt, Yves Harder, Lorenzo Rossi, Paola Canino, Simone Schiaffino, Marco Cuzzocrea

Medicina (Kaunas)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Potential Role of PSMA-Targeted PET in Salivary Gland Malignancies: An Updated Systematic Review.
Alessio Rizzo, Domenico Albano, Federica Elisei, Manuela Racca, Francesco Dondi, Marco Cuzzocrea

Diagnostics (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-Tracer Positron Emission Tomography/Computed Tomography with [F]FDG and [F]fluorocholine in a Patient with Metastatic Parathyroid Carcinoma.
Cesare Michele Iacovitti, Marco Cuzzocrea, Lauro Gianola, Gaetano Paone, Giorgio Treglia

Diagnostics (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can We Predict Skeletal Lesion on Bone Scan Based on Quantitative PSMA PET/CT Features?
Riccardo Laudicella, Matteo Bauckneht, Alexander Maurer, Jakob Heimer, Antonio G Gennari, Marco Cuzzocrea

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contrast enhanced CT on PET/CT imaging in clinical routine: an international survey.
Salvatore Annunziata, Nathalie Testart, Katharina Auf der Springe, Marco Cuzzocrea, Marie Nicod Lalonde

Front Med (Lausanne)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic role of early prostate specific antigen changes after [ Lu]Lu-PSMA radioligand therapy of metastasized prostate cancer: A meta-analysis.
Luca Giovanella, Maria Luisa Garo, Marco Cuzzocrea, Gaetano Paone, Ken Herrmann

Eur J Clin Invest· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Birds with One Stone: Hepatocellular Carcinoma and Small Cell Lung Cancer Imaged with [F]Fluorocholine Positron Emission Tomography/Computed Tomography.
Marco Cuzzocrea, Gaetano Paone, Giorgio Treglia

Diagnostics (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Evanishing Thyroid During Immune Checkpoint Inhibitor Therapy.
Marco Cuzzocrea, Gaetano Paone, Luca Ceriani, Luca Giovanella

Clin Nucl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiomics analysis improves FDG PET/CT-based risk stratification of cytologically indeterminate thyroid nodules.
Luca Giovanella, Lisa Milan, Arnoldo Piccardo, Gianluca Bottoni, Marco Cuzzocrea

Endocrine· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma.
Gaetano Paone, Mariana Raditchkova-Sarnelli, Teresa Ruberto-Macchi, Marco Cuzzocrea, Emanuele Zucca

Sci Rep· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of 18F-FDG PET/CT Metabolic Parameters in Surgically Treated Stage I Lung Adenocarcinoma Patients.
Davide Tosi, Sara Pieropan, Maria Cattoni, Gianluca Bonitta, Sara Franzi, Marco Cuzzocrea

Clin Nucl Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Significance of Hypermetabolic Lymph Nodes Detected by 2-[F]FDG PET/CT after COVID-19 Vaccination: A Systematic Review and a Meta-Analysis.
Giorgio Treglia, Marco Cuzzocrea, Luca Giovanella, Luigia Elzi, Barbara Muoio

Pharmaceuticals (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis